Solventum Corp SOLV
News
Solventum Secures FDA Clearance for Combined Wound Care Technologies
Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*
Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
Solventum to Participate in the 2026 Wells Fargo Healthcare Conference

